Literature DB >> 27518134

Guidelines for Auditory Threshold Measurement for Significant Threshold Shift.

Kathleen Campbell1, Tanisha Hammill, Michael Hoffer, Jonathan Kil, Colleen Le Prell.   

Abstract

The purpose of this article is to provide guidelines for determining a Significant Noise-Induced Threshold Shift in clinical trials involving human populations. The article reviews recommendations for the standards to be referenced for human subjects, equipment, test environment, and personnel. Additional guidelines for military populations are provided. Guidelines for the calibration of audiometers, sound booth noise levels, and immitance equipment are provided. In addition the guidance provides specific suggestions for the subjects history before study onset, and otoscopy.Test frequencies for threshold determination and methods of threshold determination are reviewed for both air conduction and bone conduction for both baseline testing and later determination of either a temporary (TTS) or permanent threshold shift (PTS). Once a Significant Noise-Induced Threshold Shift has been determined, subjects should be retested, conductive component should be ruled out or addressed, and the subject should be counseled or referred for additional medical evaluation. Guidance for reporting procedures and the computerized study database are described. Finally, experimental designs suggested for noise-induced otoprotection clinical trials are described.

Entities:  

Mesh:

Year:  2016        PMID: 27518134     DOI: 10.1097/MAO.0000000000001135

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  6 in total

Review 1.  Otoprotectants: From Research to Clinical Application.

Authors:  Colleen G Le Prell
Journal:  Semin Hear       Date:  2019-04-26

Review 2.  The audiogram: Detection of pure-tone stimuli in ototoxicity monitoring and assessments of investigational medicines for the inner ear.

Authors:  Colleen G Le Prell; Carmen C Brewer; Kathleen C M Campbell
Journal:  J Acoust Soc Am       Date:  2022-07       Impact factor: 2.482

3.  Noise-induced hearing loss and its prevention: Integration of data from animal models and human clinical trials.

Authors:  Colleen G Le Prell; Tanisha L Hammill; William J Murphy
Journal:  J Acoust Soc Am       Date:  2019-11       Impact factor: 1.840

4.  CDK2 inhibitors as candidate therapeutics for cisplatin- and noise-induced hearing loss.

Authors:  Tal Teitz; Jie Fang; Asli N Goktug; Justine D Bonga; Shiyong Diao; Robert A Hazlitt; Luigi Iconaru; Marie Morfouace; Duane Currier; Yinmei Zhou; Robyn A Umans; Michael R Taylor; Cheng Cheng; Jaeki Min; Burgess Freeman; Junmin Peng; Martine F Roussel; Richard Kriwacki; R Kiplin Guy; Taosheng Chen; Jian Zuo
Journal:  J Exp Med       Date:  2018-03-07       Impact factor: 14.307

5.  A clinical trial of nicergoline to prevent temporary threshold shift.

Authors:  Pana Klamkam; Rongrat Pagcharoenpol; Treewit Treesaranuwattana; Pichayen Silpsrikul; Pariyanan Jaruchinda; Piyalarp Wasuwat; Picha Suwannahitatorn
Journal:  Laryngoscope Investig Otolaryngol       Date:  2022-01-25

Review 6.  Prevention of Noise-Induced Hearing Loss Using Investigational Medicines for the Inner Ear: Previous Trial Outcomes Should Inform Future Trial Design.

Authors:  Colleen G Le Prell
Journal:  Antioxid Redox Signal       Date:  2021-10-04       Impact factor: 7.468

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.